Why the study?
What are the direct costs of modern management of aneurysmal subarachnoid hemorrhage in the first year after diagnosis?
What are the direct costs of modern management of aneurysmal subarachnoid hemorrhage in the first year after diagnosis?
Most direct costs in the first year after aneurysmal subarachnoid hemorrhage are driven by hospital inpatient days, suggesting that treatments reducing length of stay could be highly cost-effective.
Answers are grounded in this paper and cite their sources.
High costs of aneurysmal subarachnoid hemorrhage care are driven by inpatient stays; this cohort study leaves open whether shortening length of stay is cost-effective.
BACKGROUND AND PURPOSE: The purpose of this study was to investigate the current direct costs of modern management of patients with aneurysmal subarachnoid hemorrhage in the first year after diagnosis. METHODS: During a 1-year period, we studied all admitted patients with subarachnoid hemorrhage from a population of 2 million people. We calculated the direct costs of treatment, which included the costs of medical and nursing care and the related travel expenses of patients. We calculated true costs for all major healthcare resources. National census data, if available, and standard charges were used to determine healthcare resource expenses. RESULTS: Hospital admissions and diagnostic and therapeutic interventions in 110 patients accounted for 85% of all costs; 64% of the total direct medical costs during admission were the medical, nursing, and overhead costs alone. Patients discharged directly to home generated 4% of the total budget, whereas admission to a nursing home accounted for the remaining 11% of the total costs. Of the diagnostic and therapeutic costs, 45% was caused by imaging and 42% by surgery or coiling. Angiography alone accounted for 52% of the total imaging costs and 24% of the total diagnostic and therapeutic costs. Prescribed medication accounted for only 3% of the total budget of diagnostic and therapeutic costs. CONCLUSIONS: Most direct costs during the first year after aneurysmal subarachnoid hemorrhage are caused by the hospital inpatient days, accounting for two thirds of the total costs generated during the first year after the initial bleeding. If new costly treatments succeed in reducing the average length of inpatient hospital stays, then progress in therapy may prove cost effective and might even be cost saving.
No takes yet. Share an insight, caveat, or question.
Roos et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: